rosacea
Conditions
Interventions
Experimental group:ShuangPiZhuoYu prescription External Application
Control group:Metronidazole?gel?external?coating
Sponsors
Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients with rosacea erythematous telangiectasia and papular pustule according to Western medical diagnostic criteria; (2) The patients who were diagnosed by two dermatologists or above and meet the clinical diagnosis of roseacea toxin heat stasis syndrome; (3) 18-65 years old, male or female; (4) The patients signed the informed consent, voluntarily participated in the study, complied with the study protocol, insisted on medication, and returned to the clinic on time.
Exclusion criteria
Exclusion criteria: (1) Patients with other facial skin diseases, such as hormone dependent dermatitis; (2) The use of drugs in recent 2 weeks may affect the test results; (3) Pregnant or lactating women; (4) Have serious various diseases of primary systems; (5) Patients with other skin diseases requiring treatment; (6) Those who are allergic to therapeutic drugs; (7) Those who participate in other clinical trials at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom index and score;Efficacy evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| dermatology life quality index;Inflammatory factors assay; | — |
Countries
China
Contacts
Public ContactLang Na
Outcome results
None listed